BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19409176)

  • 1. [CD3-specific antibody-induced T-cell apoptosis and apoptotic cell uptake lead to CD3-specific antibody-induced tolerance].
    Perruche S; Saas P
    Med Sci (Paris); 2009 Apr; 25(4):325-7. PubMed ID: 19409176
    [No Abstract]   [Full Text] [Related]  

  • 2. CD3-specific antibody-induced active tolerance: from bench to bedside.
    Chatenoud L
    Nat Rev Immunol; 2003 Feb; 3(2):123-32. PubMed ID: 12563296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD3-specific antibodies: a portal to the treatment of autoimmunity.
    Chatenoud L; Bluestone JA
    Nat Rev Immunol; 2007 Aug; 7(8):622-32. PubMed ID: 17641665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
    Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF; Hough J; Henderson D; Escher A
    Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.
    Chatenoud L; Primo J; Bach JF
    J Immunol; 1997 Mar; 158(6):2947-54. PubMed ID: 9058834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-induced apoptosis of CD4+CD8+ thymocytes in the absence of clonotypic T cell antigen receptor.
    Tokoro Y; Tsuda S; Tanaka S; Nakauchi H; Takahama Y
    Eur J Immunol; 1996 May; 26(5):1012-7. PubMed ID: 8647161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD3 monoclonal antibody prolongs survival of fetal pig pancreas grafts in NOD mice.
    Mandel TE; Koulmanda M
    Transplant Proc; 1992 Oct; 24(5):2289-90. PubMed ID: 1413061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.
    Migita K; Eguchi K; Kawabe Y; Tsukada T; Mizokami A; Nagataki S
    J Clin Invest; 1995 Aug; 96(2):727-32. PubMed ID: 7543492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burn-induced immunosuppression: attenuated T cell signaling independent of IFN-gamma- and nitric oxide-mediated pathways.
    Duan X; Yarmush D; Leeder A; Yarmush ML; Mitchell RN
    J Leukoc Biol; 2008 Feb; 83(2):305-13. PubMed ID: 18024716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.